BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 6, 2019
View Archived Issues
Molecular subtyping identifies problematic lung nodules
Read More
Fusion protein hVEGF121-M2-GnRH3-hinge-MVP is immunogenic and inhibits prostate tumor growth in mice
Read More
AN-12855: improved efficacy and resistance potential vs. isoniazid in M. tuberculosis mouse model
Read More
Mayo Clinic initiates phase I study of AR-160 in relapsed or refractory B-cell NHL
Read More
Phase I study of Sc-rAAV2.5IL-1Ra in moderate knee OA now enrolling participants
Read More
Data from phase IIb study of inhaled alprazolam for acute seizure rescue treatment reported at AAN
Read More
Creston presents CRS-0540 for treating infections with resistant Gram-positive pathogens
Read More
NIAID initiates phase I study of a trispecific broadly neutralizing antibody against HIV
Read More
Cialis returns to Viagra's roots
Read More
ALY-688 shows efficacy in atropine-induced rabbit model of dry eye disease
Read More
KR-67607 shows potential as neuroprotective therapeutic agent for glaucoma
Read More
TOP-1257, a potent inhibitor of inflammation and angiogenesis
Read More
Prion may be answer to Alzheimer's amyloid riddle
Read More
Preclinical data support development of AB-2004 for GI dysfunction in autism spectrum disorder
Read More
First-in-human data presented for PBT-434 alpha-synuclein aggregation inhibitor
Read More
Syros Pharmaceuticals identifies new tyrosine-protein kinase inhibitors
Read More
Genentech and Roche present RIPK1 inhibitors
Read More
Ramot at Tel Aviv University discloses compounds for neuropathic pain
Read More
AbbVie initiates phase III study of ABBV-951 in Parkinson's disease
Read More
FDA approves Kadcyla for adjuvant treatment in HER2-positive early breast cancer setting
Read More
Shanxi Medical University patents EMSCs for cardiovascular diseases
Read More
Preliminary data from OLE study of Liproca depot suggest longer treatment intervals
Read More
SK Bioscience synthesizes compounds for RSV infections
Read More
Preliminary data from phase I study of Oraxol in angiosarcoma show complete responses
Read More
High rates of remission seen with KTE-X19 in young patients with B-cell acute lymphoblastic leukemia
Read More
Novel potent mGlu7 negative allosteric modulator with high CNS penetration and favorable properties
Read More
Kazia reports safety data from phase IIa study of GDC-0084 in newly diagnosed glioblastoma
Read More
Connect Biopharma reports phase I data and new study in atopic dermatitis with CBP-201
Read More